Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as cognitive disorders. The methods relate to a regimen of pulsed dosing of blood plasma or blood plasma fractions.
Type:
Grant
Filed:
July 11, 2019
Date of Patent:
June 22, 2021
Assignee:
Alkahest, Inc.
Inventors:
Steven P. Braithwaite, Meghan Kerrisk Campbell, Eva Czirr, Ian Gallager, Nina Huber, Sam Jackson, S. Sakura Minami
Abstract: Compositions comprising vitamin E, vitamin C, and white tea extract for treating cutaneous signs of aging are disclosed. The compositions reduce signs of wrinkles and improve other skin conditions, such as increased skin elasticity and skin softness. Moreover, the prevention or treatment of unhealthy skin, such as aged skin or skin overexposed to sunlight, may advantageously be accomplished by the administration of the compositions of the present invention The compositions includes the combination of a number of different components, which interact to provide the desired improvements to the skin Further advantageous ingredients of the compositions may comprise, naturally occurring antioxidants extracted from e g grape seeds and tomato, an extract comprising glycosaminoglycans, a transition metal component in an amount effective to bind collagen and elastic fibers and thicken skin, and a catechin-based component present in an amount sufficient to inhibit the presence of anti-collagen enzyme in the skin.
Type:
Grant
Filed:
June 24, 2005
Date of Patent:
June 22, 2021
Assignee:
Ferrosan APS
Inventors:
Annebeth Siø Jensen, Annette Strarup Kristensen, Henrik Enghusen Poulsen, Jana Vicanova, Nico Smit
Abstract: The present disclosure is in the field of pharmaceutical compositions suitable for the treatment of diseases in mammals. The disclosure provides novel compositions comprising non-pathogenic fecal microbes for treating recurrent diverticulitis and related diseases. The disclosure also provides methods for treating a subject with the compositions disclosed herein.
Abstract: A plant composition, a preparation method and an application thereof. The plant composition comprises the following components in parts by weight: 20-60 parts of lemon eucalyptus, 3-20 parts of lavender, and 2-15 parts of mint. By means of adjusting the content of lemon eucalyptus, lavender and peppermint, a synergistic effect among said three components is expressed, ensuring a repellent effect while repellent time is prolonged; introducing the plant composition into skin care products enhances a repellent effect while being safe and non-irritating.
Abstract: There is provided the use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of cardiovascular diseases, and method for the treatment thereof. The cardiovascular diseases (CVD) may comprise several diseases associated with inflammation of the heart or arteries and include coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack), atherosclerosis, stroke, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, and venous thrombosis.
Type:
Grant
Filed:
November 3, 2017
Date of Patent:
June 15, 2021
Assignee:
GROUPE SANTÉ DEVONIAN INC.
Inventors:
André P. Boulet, Theophilus J. Gana, Nathalie Boucher
Abstract: The disclosure relates to a plant based emollient composition. The composition includes palm kernel oil and an aloe vera plant extract. The composition is useful alone or as a vehicle for small quantities of herbs, vitamins, medications, minerals, vinegars, essential oils (as examples) added during the composition's liquid phase.
Abstract: The present disclosure is in the field of pharmaceutical compositions suitable for the treatment of diseases in mammals. The disclosure provides novel compositions comprising non-pathogenic fecal microbes for treating multiple sclerosis and related diseases. The disclosure also provides methods for treating a subject with the compositions disclosed herein.
Abstract: The present invention discloses a medicated plaster for treating waist pain, comprising, by weight parts, the following raw materials: Abalone shell 10-20; Fructus Xanthii 10-20; Herba Lysimachiae 15-20; Lonicera japonica 10-15; and mint oil 2-4.
Abstract: Methods of removing contaminants such as pesticides, herbicides, and fungicides from plant-derived pharmaceuticals, such as Cannabis-derived pharmaceuticals, are disclosed. Plant-derived pharmaceuticals, such as Cannabis-derived pharmaceuticals, and methods of using the plant-derived pharmaceuticals are also disclosed.
Abstract: The present invention relates to novel black cumin extract compositions and a green process for making the composition. The black cumin extract composition of the invention can be used to treat anxiety, sleep and stress disorders along with significant effect on memory enhancement. The composition is available in oil and powder forms.
Abstract: A pharmaceutical composition for treating pain including malkangni oil and cypriol oil as active ingredients, and a method of topical administration of a pharmaceutical composition on skin for relieving pain, the method including: locally applying the pharmaceutical composition on an area of skin corresponding to the pain, wherein the pharmaceutical composition including malkangni oil and cypriol oil as active ingredients.
Abstract: Compositions and methods include a synergistically effective combination of glycerol and Phyllanthus emblica extract for increasing muscle volume in response to an exercise stimulus of the corresponding muscle or muscle region.
Type:
Grant
Filed:
January 6, 2021
Date of Patent:
May 4, 2021
Assignee:
KLZ HOLDINGS, LLC
Inventors:
Tim N. Ziegenfuss, Hector L. Lopez, Bruce W. Kneller
Abstract: The present invention provides a topical formulation and method of use where the formulation comprises macqui berry or a macqui berry extract containing anthocyanins having a very high oxygen radical absorbance capacity (ORAC). The formulation provides the macqui berry in a stabilized form which includes a glucuronide or glycuronide, a photostabilizing agent, encapsulation, or light—and/or air-blocking packaging.
Abstract: Prebiotic compositions for infants containing medical-grade honey are provided. Methods of supplementing infant milk formula or breast milk with medical-grade honey to enhance growth and improve colonic microbiota are also provided.
Abstract: A fermented pollen-based composition is provided which is made by treating pollen grains with one or more natural potassium sources selected from coconut water, coconut milk, raw honey, or honeydew honey, to naturally stimulate germination of the pollen, then incubating the germinated pollen, optionally with one or more additional components selected from beeswax, oils, enzyme-containing components derived from fruit, and probiotic components, wherein the resulting composition comprises a plurality of bioactive components selected from low molecular weight peptides, fatty acids, esterified flavonoids, dicaffeoyl quinic acid isomers and dicaffeoyl tartaric acid ester or ether compounds. Topical skin compositions including the fermented pollen-based composition as an active ingredient are also provided.
Abstract: A method for combining energy supplements such as energy drinks or food items with Cannabis extract. The energy supplements include at least one energizing active ingredient of variable potency. The Cannabis extract may be produced of variable potency from at least one strain of Cannabis. The agglomerated product may be produced in various forms of food or beverages. When used, the agglomerated product may provide the typical effects of Cannabis in addition to the added energy and focus provided by energy supplements.
Abstract: A crystalline pigment or colorant composition having high color intensity and/or low sugar content, and methods and processes of preparation. The composition may comprise purified fruit and/or vegetable color juices.
Abstract: The present invention relates to a valuable product in the form of a flavonoid-containing phenol mixture having intense red coloration and to a method for obtaining a valuable-substance phase, more particularly a red-colored phase, from a native substance mixture.
Type:
Grant
Filed:
August 17, 2017
Date of Patent:
April 13, 2021
Assignee:
GEA Mechanical Equipment GmbH
Inventors:
Steffen Hruschka, Wladislawa Boszulak, Daniel Michael Martel
Abstract: The present disclosure relates to the field of drugs and health foods. Disclosed is a traditional Chinese medicine composition comprising GANODERMA polysaccharide, GRIFOLA FRONDOSA polysaccharide, ANGELICAE SINENSIS RADIX oil and CINNAMOMI CORTEX oil. Experiments show that the traditional Chinese medicine composition has a scientific formulation, synergistic functions, without toxic and side effects, and not only has nutritional value but also inhibits the growth of tumor. Comparing with individual components, the composition significantly increases the percentages of CD4+ and CD8+ cells in lymphocytes of the tumor stroma, increases body immune function, recovers normal immune surveillance function, decreases the expression rate of VEGF and TGF-? 1 positive cells in tumor tissue, assists in treating tumor, increases antitumor effects of chemotherapy drugs, improves immune status of body, has the function of restoring normal immune surveillance, preventing and assisting in treating tumor.
Abstract: The present invention provides a new use or method of use of a thylakoid extract, for oral route of administration, and a composition comprising the thylakoid extract in adjunction with an acceptable carrier for oral administration. Besides the pharmaceutical use, the thylakoid extract enters the composition of food or food supplements, or medication for its innocuity and its capacity to provide a diet enriched in anti-oxidants and anti-inflammatory compounds. Therefore, in accordance with the present invention is provided the use of athylakoid extract in the making of an oral composition for treating preventing a disease or disorder involving the formation of reactive oxygen species or inflammation. Also is provided a method for treating or preventing a disease or disorder involving the formation of reactive oxygen species inflammation in an individual, which comprises the step of orality administering an effective dose of a thylakoid extact.